COR2ED play

At COR2ED we always aim to complement the educational programmes with an online component. On this page you will find a selection of these online support programmes. You are invited to use them, and further advance your knowledge.

Prof. Sandy Srinivas and Dr Roberto Iacovelli discuss adjuvant therapy in mRCC.

Adjuvant Therapy in mRCC

GU CONNECT is an independent international group of young experts in the field of GU cancer, aiming to share best clinical and scientific practices.

In collaboration with

Four GI CONNECT members authored a paper which looks to the future for circulating tumor DNA in colorectal cancer.

Future perspectives of circulating tumor DNA in colorectal cancer

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

An overview of the SARAH study in advanced HCC is provided by Dr. Mohamed Bouattour.

The SARAH study in advanced HCC: implications for clinical practice

HCC CONNECT is an independent international group of young experts in the field of liver cancer, aiming to share best clinical and scientific practices.

In collaboration with

HCC CONNECT has summarised the highlights of EASL 2017 for you.

Patient stratification and multi disciplinary approach for patients with HCC by Dr. Catherine Frenette

HCC CONNECT is an independent international group of young experts in the field of liver cancer, aiming to share best clinical and scientific practices.

In collaboration with

The Clinical Question: What is the role of adding aspirin in PIK3CA mutated patients? has been discussed by Assoc. Prof. Gerald Prager and Prof. David Tougeron.

What is the role of adding aspirin in PIK3CA mutated patients?

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Prof. Sandy Srinivas and Prof. David Pfister discuss immunotherapy in genitourinary tumors

Immunotherapy in genitourinary tumors

GU CONNECT is an independent international group of young experts in the field of GU cancer, aiming to share best clinical and scientific practices.

In collaboration with

The Clinical Question: Is it time to re-challenge anti-EGFR in mCRC? has been discussed by Assoc. Prof. Gerald Prager, Dr. Dominik Modest and Dr. Andrea Sartore-Bianchi.

Is it time to re-challenge anti-EGFR in mCRC?

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Dr. Andrea Sartore-Bianchi, Dr. Sebastian Stintzing and Dr. Dominik Modest debate the question

Does location matter in colorectal cancer: left vs right?

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

GU CONNECT has summarised the highlights of ASCO GU 2017.

GU CONNECT update from Orlando

GU CONNECT is an independent international group of young experts in the field of GenitoUrinary (GU) cancer, aiming to share best clinical and scientific practices.

In collaboration with

GI CONNECT has summarised the highlights of
ASCO GI 2017.

GI CONNECT update from San Francisco

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

An interactive e-learning developed by a panel of world renowned experts, Dr. Carrie, Dr. Bruckert, Dr. Ballantyne and Dr. Eng.

Improving management through genetic testing for Familial Hypercholesterolaemia (FH).

Approved by the International Atherosclerosis Society (IAS) and accredited by the European Board for Accreditation in Cardiology (EBAC)

An overview of translational oncology is provided by: Dr. Erika Martinelli, Dr. Andrea Sartore-Bianchi, and Dr. Shubham Pant.

Translational Oncology

HCC CONNECT is an independent international group of young experts in the field of liver cancer, aiming to share best clinical and scientific practices.

In collaboration with

"HCC CONNECT has summarised the highlights of the recent congress of the American Association for the Study of Liver Diseases (AASLD) 2016 in Boston, USA.

HCC CONNECT update from Boston

HCC CONNECT is an independent international group of young experts in the field of liver cancer, aiming to share best clinical and scientific practices.

In collaboration with

The insights from the paper: PD-1 Blockade in Tumors with Mismatch-Repair Deficiency are discussed by Prof. David Tougeron and Dr. Sebastian Stintzing.

CRC with microsatellite instability and immunotherapies

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Dr. Thomas Winder, Dr. Andrea Sartore-Bianchi and Dr. Yu Sunakawa discuss the Clinical Question: Biomarkers: when to test, what to test and what are the consequences?

Biomarkers: when to test, what to test and what are the consequences?

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Dr. Yu Sunakawa, Prof. Tanios Bekaii-Saab and Dr. Sebasian Stintzing authored a paper ‘Reconsidering the benefit of intermittent versus continuous treatment in the maintenance treatment setting of metastatic colorectal cancer’ with the aim to reconsider the evidence for clinical benefit of intermittent versus continuous treatment in the maintenance treatment setting of mCRC and to evaluate the effect of RAS and BRAF mutational status on maintenance strategies.

GI CONNECT review paper published in Cancer Treatment Reviews

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Dr. Andrea Sartore-Bianchi, Ass. Prof. Fotios Loupakis, Dr. Guillem Argilés and Ass. Prof. Gerald Prager authored a paper ‘Challenging Chemoresistant Metastatic Colorectal cancer: therapeutic strategies from the clinic and from the laboratory’ with the aim to review the effective and well-tolerated third-line and subsequent lines of treatment; and to exploit oncogenic drivers of colorectal cancer and overcome acquired resistance.

GI CONNECT review paper published in Annals of Oncology

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Dr. Chiara Cremolini, Dr. Armin Gerger, Dr. Guillem Argilés discuss the Clinical Question: When to test for BRAF and what are the consequences?

When to test for BRAF and what are the consequences?

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Ass. Prof. Fotios Loupakis, Prof. Hans Prenen and Ass. Prof. Joleen Hubbard discuss the Clinical Question: How to treat (or not) elderly colorectal cancer patients? and Unfit: a relative concept

Treatment of elderly and unfit patients with CRC

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Ass. Prof. Gerald Prager has summarised the insights from clinical data on immunotherapies in mCRC.

Immunotherapies in mCRC

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

GU CONNECT has summarised the highlights of the recent congress of the European Society for Medical Oncology (ESMO) 2016 in Copenhagen, Denmark.

GU CONNECT update from Copenhagen

GU CONNECT is an independent international group of young experts in the field of GenitoUrinary (GU) cancer, aiming to share best clinical and scientific practices.

In collaboration with

GI CONNECT has summarised the highlights of ESMO 2016.

GI CONNECT Update from Copenhagen

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Highlights of the Poster Guided Tour at ESMO 2016 in Metastatic Prostate Cancer

Poster Guided Tour ESMO 2016

Scientific Director: Prof. Dr. Bertrand Tombal, MD, PhD

GI CONNECT has summarised the highlights of (ASCO) in Chicago and the ESMO (WCGIC).

GI CONNECT Update from Barcelona & Chicago

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

GI CONNECT has summarised the highlights of the recent ASCO GI in San Francisco.

GI CONNECT update from San Francisco

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

GI CONNECT has summarised the highlights of the ECCO-ESMO meeting in Vienna for you.

GI CONNECT update from Vienna

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Highlights of the Poster Guided Tour at ESMO 2015 in colorectal cancer

Poster Guided Tour ESMO 2015

Scientific Director: Prof. Dr. med. Dirk Arnold, MD

Highlights of the Poster Guided Tour at ESMO 2015 in hepatocellular carcinoma

Poster Guided Tour ESMO 2015

Scientific Director: Prof. Michel Ducreux, MD, PhD

Highlights of the Poster Guided Tour at ESMO 2015 in prostate cancer

Poster Guided Tour ESMO 2015

Scientific Director: Prof. Fred Saad, MD FRCS

GI CONNECT has summarised the highlights of the ASCO GI meeting in San Francisco for you.

GI CONNECT update from San Francisco

GI CONNECT is an independent international group of young experts in the field of GI cancer, aiming to share best clinical and scientific practices.

In collaboration with

Comprehensive resource for the management of kinase inhibitor-associated drug-drug interactions

In collaboration with

Guidance for the prevention and clinical management of skin toxicities with MKIs

In collaboration with

Interactive and accredited e-learning in Glioblastoma Multiforme (GBM)

http://elevatehealth.eu/gbm

Scientific Expert: Dr. Alba A. Brandes, MD

In collaboration with

Highlights of the Poster Guided Tour at ESMO 2014 on colorectal cancer

ESMO 2014

Poster Guided Tour ESMO 2014

Scientific Director: Prof. Dr. med. Dirk Arnold, MD